How is the Q32 Bio Inc. today?

The Q32 Bio Inc. today is trading in the down by -3.12% at 1.55.

How has Q32 Bio Inc. performed historically?

The Q32 Bio Inc. is currently trading down -3.12% on an intraday basis in the past week the index fell -8.82%. The index has been down -28.24% in the past quarter and fell -91.48% in the past year. You can view this in the overview section.

What is Q32 Bio Inc. Annual Net Profit?

Q32 Bio Inc. Annual Net Profit rose 11.18% in the last year to $47.73 M. Its sector's average net profit growth for the last fiscal year was -14.05%.

What is Q32 Bio Inc. Price to Earning Ratio?

Q32 Bio Inc. Price to Earning Ratio is -0.32, which is negative.

What is Q32 Bio Inc. Stock Price?

Q32 Bio Inc. Stock Price fell 91.48% and underperformed its sector by 246.71% in the past year.

What is Q32 Bio Inc. Quarterly Net profit?

Q32 Bio Inc. Quarterly Net profit fell 1,172.01% YoY to $11.03 M. Its sector's average net profit growth YoY for the quarter was -236.06%.

What is Q32 Bio Inc. Debt to Equity Ratio?

Q32 Bio Inc. Debt to Equity Ratio of 3.33 is higher than 1. This implies that company assets are financed through debt.

What is Q32 Bio Inc. Mutual Fund Holding?

Q32 Bio Inc. Mutual Fund Holding decreased by 0.64% in the last quarter to 12.26.

What is Q32 Bio Inc. Promoter Share Holding?

Q32 Bio Inc. Promoter Share Holding stayed the same in the most recent quarter at 0.16%.

What is Q32 Bio Inc. Interest Coverage Ratio?

Q32 Bio Inc. Interest Coverage Ratio is -40.9, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Q32 Bio Inc. Institutional Holding?

Q32 Bio Inc. Institutional Holding decreased by 12.22% in the last quarter to 58.06.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
Q32 BIO INC.

Q32 Bio Inc. XNAS: QTTB

Q32 Bio Inc. Live Share Price Today, Share Analysis and Chart

Name: Q32 Bio Inc.: Is Infosys Ltd. worth buying?
Item: Q32 Bio Inc.
Rating: 0.47200
Author: Trendlyne DVM scores

about

Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its pro...

1.55 -0.05 (-3.12%)

97.12% Fall from 52W High

84,442

XNAS Volume

XNAS 20 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

18.9 / 100

1Yr Price target upside is 782%

3 analysts

Q32 Bio Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Q32 Bio Inc. Live Share Price Today, Share Analysis and Chart

Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its pro...

97.12% Fall from 52W High

SWOT Analysis

Q32 Bio Inc. Live Price Chart

Q32 Bio Inc. FAQ

How is Q32 Bio Inc. today?

Q32 Bio Inc. today is trading in the red, and is down by -3.12% at 1.55.

How has Q32 Bio Inc. performed historically?

Q32 Bio Inc. is currently trading down -3.12% on an intraday basis. In the past week the stock fell -8.82%. stock has been down -28.24% in the past quarter and fell -91.48% in the past year. You can view this in the overview section.